← 홈

CGT · IL-12 / IL-23

4개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4개
CGTBiologicstaleRoswell Park Cancer InstitutePhase 1

EGFRt/19-28z/IL-12 CAR T-lymphocytes (EGFRt/19-28z/IL-12 CAR T-lymphocytes)

Recurrent Chronic Lymphocytic Leukemia; Recurrent Diffuse Large B-Cell Lymphoma · EGFR

#EGFR#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 DISCONTINUED
CGTBiologicstaleThe Methodist Hospital Research…Phase 2

IL-12 gene therapy (IL-12 gene therapy)

Triple Negative Breast Cancer; Anthracycline-refractory TNBC · FRα

#FR#CGT#Phase2#세포유전치료#CAR-T+4
효능 ORR 90%임상시험 1상태 DISCONTINUED
CGTBiologicstaleXiaorong WuPhase 2

Novel oncolytic virus Ad-TD-nsIL12 (Novel oncolytic virus Ad-TD-nsIL12)

Glioma · Glioma

#Glioma#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
CGTBiologicstaleBeijing Bio-Targeting Therapeut…Phase 1

Novel oncolytic virus Ad-TD-nsIL12（BioTTT001） (Novel oncolytic virus Ad-TD-nsIL12（BioTTT001）)

High-grade Glioma · High-grade Glioma

#High-gradeGlioma#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING